Adrenergic receptors of normal and asthmatic airways.
D000316:Adrenergic alpha-Agonists / Q000009:adverse effects; D000420:Albuterol / Q000627:therapeutic use; D001249:Asthma / Q000503:physiopathology*; D001986:Bronchial Spasm / Q000188:drug therapy; D002395:Catecholamines / Q000502:physiology; D004305:Dose-Response Relationship, Drug; D006632:Histamine / Q000009:adverse effects / Q000097:blood; D006801:Humans; D013948:Moxisylyte / Q000627:therapeutic use; D009129:Muscle Tonus; D009130:Muscle, Smooth / Q000294:innervation; D010646:Phentolamine / Q000627:therapeutic use; D011217:Practolol / Q000031:analogs & derivatives / Q000378:metabolism; D011294:Prenalterol; D011942:Receptors, Adrenergic, alpha / Q000502:physiology; D011943:Receptors, Adrenergic, beta / Q000502:physiology; D012137:Respiratory System / Q000294:innervation*; D013564:Sympathetic Nervous System / Q000502:physiology; D013566:Sympathomimetics / Q000502:physiology
D000316:Adrenergic alpha-Agonists; D002395:Catecholamines; D011942:Receptors, Adrenergic, alpha; D011943:Receptors, Adrenergic, beta; D013566:Sympathomimetics; D006632:Histamine; D011294:Prenalterol; D013948:Moxisylyte; D000420:Albuterol; D011217:Practolol; D010646:Phentolamine